1. lncRNA CASC2 Enhances 131I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
   Ling Tao et al, 2020, BioMed Research International CrossRef
2. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
   Shunsuke Okamura et al, 2021, BMC Cancer CrossRef
3. MicroRNA‑155 promotes apoptosis of colonic smooth muscle cells and aggravates colonic dysmotility by targeting IGF‑1
   Xiaoxue Shen et al, 2020, Experimental and Therapeutic Medicine CrossRef
4. MicroRNA Gene Expression Profile of Colorectal Cancer in Saudi Population
   Ebtehal Abduh Ahmed et al, 2024, International Journal of Pharmacology CrossRef
5. Autophagy-Mediated Chemotherapy Resistance of Gastric Cancer
   亚利 郝, 2021, Advances in Clinical Medicine CrossRef
6. MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma
   Bowen Liu et al, 2022, Frontiers in Oncology CrossRef
7. Genetics of Colorectal Cancer Racial Disparities
   Jennie Williams et al, 2022, Gene Expression CrossRef
8. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
   Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
9. Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3
   Xiaohua Luo et al, 2022, Mediators of Inflammation CrossRef
10. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer
    Adil Ali Sayyed et al, 2021, Molecular Pharmaceutics CrossRef
11. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
    Yanan Wu et al, 2023, Molecular Diagnosis & Therapy CrossRef